{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:52:17Z","timestamp":1775091137776,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ejso.2024.108047","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T11:31:46Z","timestamp":1708515106000},"page":"108047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Survival benefit of adjuvant chemotherapy in patients with resected gallbladder adenocarcinoma: An updated retrospective cohort analysis"],"prefix":"10.1016","volume":"50","author":[{"given":"Yizhi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qifan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongkai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weilin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2024.108047_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-022-00398-y","article-title":"Gallbladder cancer","volume":"8","author":"Roa","year":"2022","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.ejso.2024.108047_bib2","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jama.2018.11815","article-title":"Gallbladder cancer","volume":"320","author":"Baiu","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ejso.2024.108047_bib3","first-page":"12","article-title":"Cancer statistics","volume":"74","author":"Siegel","year":"2024","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.ejso.2024.108047_bib4","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/jso.27450","article-title":"Global epidemiological trends and variations in the burden of gallbladder cancer","volume":"128","author":"Vuthaluru","year":"2023","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108047_bib5","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1245\/s10434-023-13531-2","article-title":"Benchmarks and Geographic differences in gallbladder cancer surgery: an international multicenter study","volume":"30","author":"Vega","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108047_bib6","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.3748\/wjg.v29.i16.2369","article-title":"Current status and progress in laparoscopic surgery for gallbladder carcinoma","volume":"29","author":"Sun","year":"2023","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejso.2024.108047_bib7","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.12998\/wjcc.v11.i16.3694","article-title":"Application of laparoscopic surgery in gallbladder carcinoma","volume":"11","author":"Wu","year":"2023","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.ejso.2024.108047_bib8","doi-asserted-by":"crossref","first-page":"18861","DOI":"10.1002\/cam4.6513","article-title":"Improved long-term outcomes after innovative preoperative evaluation and conception of precise surgery for gallbladder cancer","volume":"12","author":"Jia","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.ejso.2024.108047_bib9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jamasurg.2013.5137","article-title":"Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis","volume":"149","author":"Mavros","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ejso.2024.108047_bib10","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1001\/jamasurg.2020.1973","article-title":"Very early recurrence after liver resection for intrahepatic cholangiocarcinoma: considering alternative treatment approaches","volume":"155","author":"Tsilimigras","year":"2020","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ejso.2024.108047_bib11","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1245\/s10434-023-13567-4","article-title":"Trends in receipt of adjuvant chemotherapy and its impact on survival in resected biliary tract cancers","volume":"30","author":"Rhodin","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108047_bib12","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"BILCAP study group. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2024.108047_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(22)02038-4","article-title":"Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG). Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial","volume":"401","author":"Nakachi","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2024.108047_bib14","article-title":"Adjuvant chemoradiotherapy in resected gallbladder cancer: a SEER-based study","volume":"9","author":"Jiang","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.ejso.2024.108047_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.616170","article-title":"The efficacy of adjuvant chemoradiotherapy in early-stage gallbladder adenocarcinoma depends on the tumor invasion depth and differentiation level","volume":"10","author":"Liang","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2024.108047_bib16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11605-022-05495-7","article-title":"Role of peri-operative chemotherapy in stage II (pT2N0) gallbladder cancers","volume":"27","author":"Kunte","year":"2023","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.ejso.2024.108047_bib17","unstructured":"National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov). SEER\u2217Stat Database: Incidence - SEER Research Data, 17 Registries, Nov 2021 Sub (2000-2019)-Linked To County Attributes - Time Dependent (1990-2019) Income\/Rurality, 1969-2020 Counties, National Cancer Institute, DCCPS, Surveillance Research Pro-gram, released August 2023, based on the November 2020 submission."},{"key":"10.1016\/j.ejso.2024.108047_bib18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3390\/cancers13030547","article-title":"Validation of the 8th edition American Joint commission on cancer (AJCC) gallbladder cancer staging system: prognostic discrimination and identification of key predictive factors","volume":"13","author":"Giannis","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2024.108047_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.106165","article-title":"STROCSS Group. STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery","volume":"96","author":"Mathew","year":"2021","journal-title":"Int J Surg"},{"key":"10.1016\/j.ejso.2024.108047_bib20","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/sim.5984","article-title":"The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments","volume":"33","author":"Austin","year":"2014","journal-title":"Stat Med"},{"key":"10.1016\/j.ejso.2024.108047_bib21","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1097\/JS9.0000000000000589","article-title":"Survival benefit and impact of adjuvant chemotherapy following systemic neoadjuvant chemotherapy in patients with resected pancreas ductal adenocarcinoma: a retrospective cohort study","volume":"109","author":"Pu","year":"2023","journal-title":"Int J Surg"},{"key":"10.1016\/j.ejso.2024.108047_bib22","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization","volume":"10","author":"Camp","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejso.2024.108047_bib23","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1200\/JCO.18.00050","article-title":"Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): a randomized phase III study","volume":"37","author":"Edeline","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2024.108047_bib24","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s11605-021-05143-6","article-title":"Prospective randomized controlled trial comparing adjuvant chemotherapy vs. No chemotherapy for patients with carcinoma of gallbladder undergoing curative resection","volume":"26","author":"Saluja","year":"2022","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.ejso.2024.108047_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-20933-x","article-title":"A\u00a0novel nomogram based on log odds of positive lymph nodes to predict survival for non-metastatic gallbladder adenocarcinoma after surgery","volume":"12","author":"Jiang","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejso.2024.108047_bib26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ejso.2021.09.002","article-title":"Adjuvant radiotherapy improves long-term survival after resection for gallbladder cancer A population-based cohort study","volume":"48","author":"Kamarajah","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108047_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13014-020-1459-x","article-title":"A\u00a0meta-analysis of the efficacy of postoperative adjuvant radiotherapy versus no radiotherapy for extrahepatic cholangiocarcinoma and gallbladder carcinoma","volume":"15","author":"Ren","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ejso.2024.108047_bib28","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1200\/JCO.2014.60.2219","article-title":"Swog S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma","volume":"33","author":"Ben-Josef","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2024.108047_bib29","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1245\/s10434-022-12863-9","article-title":"Adjuvant chemoradiation in patients with lymph node-positive biliary tract cancers: secondary analysis of a single-arm clinical trial (SWOG 0809)","volume":"30","author":"Gholami","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108047_bib30","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1200\/JCO.18.02178","article-title":"Adjuvant therapy for resected biliary tract cancer: ASCO clinical practice guideline","volume":"37","author":"Shroff","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2024.108047_bib31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijsu.2018.02.052","article-title":"Adjuvant systemic therapy after resection of node positive gallbladder cancer: time for a well-designed trial? (Results of a US-national retrospective cohort study)","volume":"52","author":"Bergquist","year":"2018","journal-title":"Int J Surg"},{"key":"10.1016\/j.ejso.2024.108047_bib32","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.hpb.2023.08.010","article-title":"Physician decision-making in the use of adjuvant chemotherapy for lymph node-positive gallbladder cancer","volume":"25","author":"White","year":"2023","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.ejso.2024.108047_bib33","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s00423-023-03119-5","article-title":"Metastatic lymph node ratio as an important prognostic factor in advanced gallbladder carcinoma with at least 6 lymph nodes retrieved","volume":"408","author":"Wang","year":"2023","journal-title":"Langenbeck's Arch Surg"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324000994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324000994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:53:10Z","timestamp":1760061190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798324000994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0748798324000994"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108047","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival benefit of adjuvant chemotherapy in patients with resected gallbladder adenocarcinoma: An updated retrospective cohort analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108047"}}